These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28430911)
1. A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker. Moura-Ferreira S; Gonçalves H; Oliveira M; Primo J; Fonseca P; Ribeiro J; Santos E; Pelicano N; Martins D; Gama V Europace; 2017 Dec; 19(12):2042-2046. PubMed ID: 28430911 [TBL] [Abstract][Full Text] [Related]
2. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
3. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
4. Complications of permanent cardiac pacing in patients with persistent left superior vena cava. Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508 [TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial. Merkely B; Kosztin A; Roka A; Geller L; Zima E; Kovacs A; Boros AM; Klein H; Wranicz JK; Hindricks G; Clemens M; Duray GZ; Moss AJ; Goldenberg I; Kutyifa V Europace; 2017 Sep; 19(9):1549-1555. PubMed ID: 28339581 [TBL] [Abstract][Full Text] [Related]
6. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
7. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort. Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521 [TBL] [Abstract][Full Text] [Related]
8. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death. Zhu DWX; Chu MM; House CM Europace; 2017 Dec; 19(12):2007-2014. PubMed ID: 27940933 [TBL] [Abstract][Full Text] [Related]
9. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator. Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973 [TBL] [Abstract][Full Text] [Related]
10. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464 [TBL] [Abstract][Full Text] [Related]
12. When Ventricular Safety Standby Does Not Work. Haldar SK; Steed B; Watkins S; Nair K J Cardiovasc Electrophysiol; 2017 May; 28(5):574-575. PubMed ID: 28054730 [TBL] [Abstract][Full Text] [Related]
13. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators. Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354 [TBL] [Abstract][Full Text] [Related]
14. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database. Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076 [TBL] [Abstract][Full Text] [Related]
16. T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy. Lezcano AO; Aracama JM; Ayestaran VU; Urra FG Cardiol J; 2009; 16(6):580-1. PubMed ID: 19950098 [TBL] [Abstract][Full Text] [Related]
17. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients. Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467 [TBL] [Abstract][Full Text] [Related]
18. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT. Kosiuk J; Krause M; Doering M; Weber A; Breithardt OA; Dinov B; Darma A; Lucas J; Muessigbrodt A; Bode K; Kuehl M; Dagres N; Hindricks G; Bollmann A; Richter S Heart Vessels; 2020 Jan; 35(1):104-109. PubMed ID: 31227877 [TBL] [Abstract][Full Text] [Related]
19. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL; Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [TBL] [Abstract][Full Text] [Related]
20. Optimal pacing for right ventricular and biventricular devices: minimizing, maximizing, and right ventricular/left ventricular site considerations. Gillis AM Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):968-77. PubMed ID: 25336367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]